FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 63323-895 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerFresenius Kabi USA, LLC
Marketing categoryNew Drug Application (innovator) · App NDA210632
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsLEVOTHYROXINE SODIUM (100 ug/mL)
Marketing started20180529
Package count1

External sources

Source: openFDA. Public-domain (CC0).